PDS Biotechnology (PDSB) Tops Q2 EPS by 8c

PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.20), $0.08 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M